Launching into a crowded therapeutic category: sequencing market access, medical affairs, and commercial
Successful drug launches in crowded markets depend on sequencing, not marketing.
Marcus Thibodeau
Section
Features
4 stories in Features.
HCP engagement after the rep: what field teams and digital channels each still do better
Field reps and digital channels each solve different engagement problems.
Marcus Thibodeau
Modular content in pharma marketing: what breaks when you try to reuse approved claims across channels
Modular content only works if you account for how channels change what claims actually mean.
Priya Nambiar
What actually slows down MLR review, and why adding more reviewers rarely fixes it
The bottleneck is sloppy submissions, not reviewer workload.
Renata Solis-Vega